In a new study, researchers aimed to determine the rate of hospitalizations associated with a new treatment combination compared with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers in patients with heart failure with reduced ejection fraction. | Read More
subcutaneous injection
The US Food and Drug Administration has approved a subcutaneous injection for the treatment of a rare and serious genetic disease involving the inability to break down phenylananine. | Read More
blood pressure
In a new study, researchers examined the proportion of US adults with hypertension who are recommended for antihypertensive treatment and the risk of cardiovascular disease and all-cause mortality under the new... | Read More
Various chronic inflammatory conditions, such as rheumatoid arthritis and psoriasis, are known to be associated with an increased cardiovascular risk. In a new study, researchers aimed to examine whether severe eczema was also associated with this risk, and how the risk... | Read More